• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

asperlin 可刺激能量消耗并调节高脂肪饮食喂养的小鼠肠道微生物群。

Asperlin Stimulates Energy Expenditure and Modulates Gut Microbiota in HFD-Fed Mice.

机构信息

Pharmacology and Toxicology Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China.

State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China.

出版信息

Mar Drugs. 2019 Jan 9;17(1):38. doi: 10.3390/md17010038.

DOI:10.3390/md17010038
PMID:30634484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6356881/
Abstract

Asperlin is a marine-derived, natural product with antifungal, anti-inflammatory and anti-atherosclerotic activities. In the present study, we showed that asperlin effectively prevented the development of obesity in high-fat diet (HFD)-fed mice. Oral administration of asperlin for 12 weeks significantly suppressed HFD-induced body weight gain and fat deposition without inhibiting food intake. Hyperlipidemia and liver steatosis were also substantially ameliorated. A respiratory metabolism monitor showed that asperlin efficiently increased energy expenditure and enhanced thermogenic gene expression in adipose tissue. Accordingly, asperlin-treated mice showed higher body temperature and were more tolerant of cold stress. Meanwhile, asperlin also increased the diversity and shifted the structure of gut microbiota. Oral administration of asperlin markedly increased the relative abundance of Bacteroidetes, leading to a higher Bacteroidetes-to-Fimicutes ratio. The HFD-induced abnormalities at both phylum and genus levels were all remarkably recovered by asperlin. These results demonstrated that asperlin is effective in preventing HFD-induced obesity and modulating gut microbiota. Its anti-obesity properties may be attributed to its effect on promoting energy expenditure.

摘要

asperlin 是一种来源于海洋的天然产物,具有抗真菌、抗炎和抗动脉粥样硬化活性。在本研究中,我们表明 asperlin 可有效预防高脂肪饮食(HFD)喂养小鼠肥胖的发生。asperlin 口服给药 12 周可显著抑制 HFD 诱导的体重增加和脂肪沉积,而不抑制食物摄入。高脂血症和肝脂肪变性也得到了明显改善。呼吸代谢监测仪显示,asperlin 可有效增加能量消耗,并增强脂肪组织中的产热基因表达。因此,asperlin 处理的小鼠体温更高,对冷应激的耐受性更强。同时,asperlin 还增加了肠道微生物群的多样性并改变了其结构。asperlin 口服给药可显著增加拟杆菌门的相对丰度,导致拟杆菌门到厚壁菌门的比值升高。asperlin 可显著恢复 HFD 诱导的门和属水平的异常。这些结果表明,asperlin 可有效预防 HFD 诱导的肥胖,并调节肠道微生物群。其抗肥胖特性可能与其促进能量消耗的作用有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/7ddf25c0faee/marinedrugs-17-00038-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/dfac8f431928/marinedrugs-17-00038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/6fb59db8e7d5/marinedrugs-17-00038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/291e3e1f5ef2/marinedrugs-17-00038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/36093055abaa/marinedrugs-17-00038-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/5310f4e5d0ef/marinedrugs-17-00038-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/d0d7d0ee25c1/marinedrugs-17-00038-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/7ddf25c0faee/marinedrugs-17-00038-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/dfac8f431928/marinedrugs-17-00038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/6fb59db8e7d5/marinedrugs-17-00038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/291e3e1f5ef2/marinedrugs-17-00038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/36093055abaa/marinedrugs-17-00038-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/5310f4e5d0ef/marinedrugs-17-00038-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/d0d7d0ee25c1/marinedrugs-17-00038-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdc/6356881/7ddf25c0faee/marinedrugs-17-00038-g007.jpg

相似文献

1
Asperlin Stimulates Energy Expenditure and Modulates Gut Microbiota in HFD-Fed Mice.asperlin 可刺激能量消耗并调节高脂肪饮食喂养的小鼠肠道微生物群。
Mar Drugs. 2019 Jan 9;17(1):38. doi: 10.3390/md17010038.
2
Asperlin Inhibits LPS-Evoked Foam Cell Formation and Prevents Atherosclerosis in ApoE Mice.阿司匹林抑制 LPS 诱导的泡沫细胞形成并预防载脂蛋白 E 基因敲除小鼠的动脉粥样硬化。
Mar Drugs. 2017 Nov 14;15(11):358. doi: 10.3390/md15110358.
3
Suppression of High-Fat Diet-Induced Obesity by Platycodon Grandiflorus in Mice Is Linked to Changes in the Gut Microbiota.桔梗通过改变肠道微生物群抑制高脂饮食诱导的肥胖。
J Nutr. 2020 Sep 1;150(9):2364-2374. doi: 10.1093/jn/nxaa159.
4
Dietary α-lactalbumin alters energy balance, gut microbiota composition and intestinal nutrient transporter expression in high-fat diet-fed mice.饮食中的 α-乳白蛋白改变高脂肪饮食喂养小鼠的能量平衡、肠道微生物群落组成和肠道营养转运蛋白表达。
Br J Nutr. 2019 May;121(10):1097-1107. doi: 10.1017/S0007114519000461. Epub 2019 Mar 5.
5
Jamun (Eugenia jambolana Lam.) Fruit Extract Prevents Obesity by Modulating the Gut Microbiome in High-Fat-Diet-Fed Mice.罗望子(Eugenia jambolana Lam.)果提取物通过调节高脂肪饮食喂养小鼠的肠道微生物组预防肥胖。
Mol Nutr Food Res. 2019 May;63(9):e1801307. doi: 10.1002/mnfr.201801307. Epub 2019 Feb 25.
6
Melatonin prevents obesity through modulation of gut microbiota in mice.褪黑素通过调节小鼠肠道微生物群预防肥胖。
J Pineal Res. 2017 May;62(4). doi: 10.1111/jpi.12399. Epub 2017 Mar 10.
7
Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.红肉火龙果花青素通过调节小鼠肠道微生物群,预防饮食诱导的肥胖、肝脏脂肪变性和胰岛素抵抗。
J Gastroenterol Hepatol. 2016 Aug;31(8):1462-9. doi: 10.1111/jgh.13278.
8
Fubrick tea attenuates high-fat diet induced fat deposition and metabolic disorder by regulating gut microbiota and caffeine metabolism.茯砖茶通过调节肠道微生物群和咖啡因代谢减轻高脂饮食诱导的脂肪沉积和代谢紊乱。
Food Funct. 2020 Aug 1;11(8):6971-6986. doi: 10.1039/d0fo01282c. Epub 2020 Jul 22.
9
Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets.肠道微生物群介导膳食 β-羟基-β-甲基丁酸(HMB)对高脂肪饮食诱导肥胖的保护作用。
FASEB J. 2019 Sep;33(9):10019-10033. doi: 10.1096/fj.201900665RR. Epub 2019 Jun 5.
10
Inhibitory effects of fermented Ougan () juice on high-fat diet-induced obesity associated with white adipose tissue browning and gut microbiota modulation in mice.发酵乌甘()汁对高脂肪饮食诱导肥胖的抑制作用及其对白色脂肪组织棕色化和肠道微生物群调节的影响。
Food Funct. 2021 Oct 4;12(19):9300-9314. doi: 10.1039/d0fo03423a.

引用本文的文献

1
Complexes of Soluble Dietary Fiber and Polyphenols from Lotus Root Regulate High-Fat Diet-Induced Hyperlipidemia in Mice.莲藕中可溶性膳食纤维与多酚的复合物对高脂饮食诱导的小鼠高脂血症具有调节作用。
Antioxidants (Basel). 2024 Apr 16;13(4):466. doi: 10.3390/antiox13040466.
2
Potential efficacy and mechanism of eight mild-natured and bitter-flavored TCMs based on gut microbiota: A review.基于肠道菌群的八种性味苦寒中药的潜在功效及作用机制:综述
Chin Herb Med. 2023 Dec 13;16(1):42-55. doi: 10.1016/j.chmed.2023.08.001. eCollection 2024 Jan.
3
Developing natural marine products for treating liver diseases.

本文引用的文献

1
Cordycepin promotes browning of white adipose tissue through an AMP-activated protein kinase (AMPK)-dependent pathway.虫草素通过一种依赖于腺苷酸活化蛋白激酶(AMPK)的途径促进白色脂肪组织的褐变。
Acta Pharm Sin B. 2019 Jan;9(1):135-143. doi: 10.1016/j.apsb.2018.10.004. Epub 2018 Oct 17.
2
Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis.奥利司他治疗非酒精性脂肪性肝病的疗效:一项系统评价与荟萃分析。
Biomed Rep. 2018 Jul;9(1):90-96. doi: 10.3892/br.2018.1100. Epub 2018 May 22.
3
Oral administration of rutile and anatase TiO nanoparticles shifts mouse gut microbiota structure.
开发用于治疗肝脏疾病的天然海洋产品。
World J Clin Cases. 2022 Mar 16;10(8):2369-2381. doi: 10.12998/wjcc.v10.i8.2369.
4
Biocontrol Potential of Species Producing Antimicrobial Metabolites.产生抗菌代谢产物的物种的生物防治潜力
Front Microbiol. 2021 Dec 23;12:804333. doi: 10.3389/fmicb.2021.804333. eCollection 2021.
5
Broccoli Florets Supplementation Improves Insulin Sensitivity and Alters Gut Microbiome Population-A Steatosis Mice Model Induced by High-Fat Diet.西兰花小花补充剂可改善胰岛素敏感性并改变肠道微生物群组成——高脂饮食诱导的脂肪肝小鼠模型
Front Nutr. 2021 Jul 28;8:680241. doi: 10.3389/fnut.2021.680241. eCollection 2021.
6
Current Research Landscape of Marine-Derived Anti-Atherosclerotic Substances.海洋来源抗动脉粥样硬化物质的研究现状。
Mar Drugs. 2020 Aug 25;18(9):440. doi: 10.3390/md18090440.
7
Osteoarthritis Is a Low-Grade Inflammatory Disease: Obesity's Involvement and Herbal Treatment.骨关节炎是一种低度炎症性疾病:肥胖的影响及草药治疗
Evid Based Complement Alternat Med. 2019 Nov 4;2019:2037484. doi: 10.1155/2019/2037484. eCollection 2019.
8
Relationship between Changes in Microbiota and Liver Steatosis Induced by High-Fat Feeding-A Review of Rodent Models.高脂肪喂养诱导的肝脂肪变性中微生物群变化的关系:啮齿动物模型综述。
Nutrients. 2019 Sep 9;11(9):2156. doi: 10.3390/nu11092156.
口服锐钛矿和金红石型 TiO2 纳米颗粒会改变小鼠肠道微生物群落结构。
Nanoscale. 2018 Apr 26;10(16):7736-7745. doi: 10.1039/c8nr00386f.
4
Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease.肠道微生物群作为非酒精性脂肪性肝病炎症的驱动因素。
Mediators Inflamm. 2018 Jan 31;2018:9321643. doi: 10.1155/2018/9321643. eCollection 2018.
5
The developing gut microbiota and its consequences for health.发育中的肠道微生物群及其对健康的影响。
J Dev Orig Health Dis. 2018 Dec;9(6):590-597. doi: 10.1017/S2040174418000119. Epub 2018 Mar 22.
6
Gut Microbiota: An Integral Moderator in Health and Disease.肠道微生物群:健康与疾病中的一个重要调节因素。
Front Microbiol. 2018 Feb 21;9:151. doi: 10.3389/fmicb.2018.00151. eCollection 2018.
7
Gut microbiota, hypertension and chronic kidney disease: Recent advances.肠道微生物群、高血压和慢性肾脏病:最新进展。
Pharmacol Res. 2019 Jun;144:390-408. doi: 10.1016/j.phrs.2018.01.013. Epub 2018 Jan 31.
8
The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo.富勒醇纳米颗粒通过调节体内肠道微生物群来发挥抗高血脂作用。
Part Fibre Toxicol. 2018 Jan 17;15(1):5. doi: 10.1186/s12989-018-0241-9.
9
Deviations in energy sensing predict long-term weight change in overweight Native Americans.超重的美洲原住民的能量感知偏差可预测其长期体重变化。
Metabolism. 2018 May;82:65-71. doi: 10.1016/j.metabol.2017.12.013. Epub 2018 Jan 3.
10
Asperlin Inhibits LPS-Evoked Foam Cell Formation and Prevents Atherosclerosis in ApoE Mice.阿司匹林抑制 LPS 诱导的泡沫细胞形成并预防载脂蛋白 E 基因敲除小鼠的动脉粥样硬化。
Mar Drugs. 2017 Nov 14;15(11):358. doi: 10.3390/md15110358.